# CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia

> clinical trial · VERIFIED · 2026-07-16

Status: ACTIVE_NOT_RECRUITING · Sponsor: University of California, Irvine · Condition: Acute Myelogenous Leukemia (AML) Due to Therapy

- Company: University of California, Irvine
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT04231851

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.